Previous Article | Next Article ![]()
Applied and Environmental Microbiology, June 2005, p. 2999-3006, Vol. 71, No. 6
0099-2240/05/$08.00+0 doi:10.1128/AEM.71.6.2999-3006.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Ying Wen,1,
,
Hidemi Hatabayashi,1
Hatsue Arai,1
Chiemi Aoki,1
Kimiko Yabe,1* and
Hiromitsu Nakajima2
National Food Research Institute, Tsukuba, Ibaraki 305-8642, Japan,1 Faculty of Agriculture, Tottori University, Koyama, Tottori 680-8553, Japan2
Received 6 October 2004/ Accepted 15 December 2004
|
|
|---|
|
|
|---|
We recently reported that two enzymes are involved in the pathway from 5'-hydroxyaverantin (HAVN) to averufin (AVR); HAVN dehydrogenase catalyzes the conversion of HAVN to 5'-oxoaverantin (OAVN), and OAVN cyclase catalyzes the next reaction from OAVN to AVR (13). These enzymes have been purified and characterized. The identity of HAVN dehydrogenase with the gene product of adhA (3) was confirmed by tryptic digestion and matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis (13). The molecular masses of natural OAVN cyclase and denatured OAVN cyclase are 158 kDa and 79 kDa, respectively.
In this study, we determined the amino acid sequence of the enzyme to find the gene encoding the OAVN cyclase. Surprisingly, the N-terminal sequence of OAVN cyclase was the same as a stretch of the versiconal (VHOH) cyclase sequence that was deduced from the reported vbs gene (15). VHOH cyclase has been purified independently by Lin and Anderson (10) and by McGuire et al. (11). VHOH cyclase catalyzes the conversion of VHOH to versicolorin B (VB) and is also called VB synthase (11, 14, 15). This enzyme shows strict stereospecificity to the (1'R,2'S) configuration of VHOH, and it determines the configurations of the subsequent intermediates, as well as the final products, aflatoxins (11, 22). To establish the identity of OAVN cyclase and VHOH cyclase, we conducted the following three experiments: (i) competition between OAVN and VHOH for the enzyme in the cytosol fraction of A. parasiticus, (ii) transformation of Pichia pastoris with vbs and conversion of OAVN to AVR by the expressed VHOH cyclase, and (iii) disruption of the vbs gene in A. parasiticus, followed by characterization of the disruptant. This work is the first report of an enzyme that is involved in two distinct and disconnected reactions in aflatoxin biosynthesis.
|
|
|---|
Standard samples.
HAVN and averufanin (AVF) were isolated from cultures of Emericella heterothallica IFO30842(24). OAVN was prepared by incubation of HAVN with the partially purified HAVN dehydrogenase obtained from the cytosol of A. parasiticus NIAH-26 (13). Versiconal hemiacetal acetate (VHA) was purified from mycelia of the mutant A. parasiticus NIAH-9 cultured in YES medium supplemented with dichlorvos (23). VB (6) and AVR (24) were prepared from mycelia of A. versicolor (Vuill.) Tiraboschi. VHOH was prepared by incubation of VHA with porcine liver esterase followed by extraction with ethyl acetate (1). Averantin (AVN) was prepared from an AVN-accumulating mutant (20). The concentrations of these metabolites were determined based on the UV absorption spectra in methanol by using the following molar absorption coefficients (
max): for AVN, 6,700 M1 cm1 (453 nm); for HAVN, 7,100 M1 cm1 (466 nm); for AVF, 7,600 M1 cm1 (468 nm); for OAVN, 8,500 M1 cm1 (457 nm); for AVR, 10,500 M1 cm1 (454 nm); for VHA, 7,300 M1 cm1 (480 nm); and for VB, 8,700 M1 cm1 (450 nm).
Determination of N-terminal amino acid sequence of OAVN cyclase.
OAVN cyclase purified from the cytosol of A. parasiticus NIAH-26 as previously described (13) was subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis using a 10% polyacrylamide gel (8, 13), and the proteins on the gel were blotted onto a polyvinylidene difluoride membrane (Immobilon P; Millipore) with a semidry blotting system (model AE 6675; Atto, Tokyo, Japan). The part of the membrane corresponding to the OAVN cyclase protein (79 kDa) was cut out and applied to an automated Edman degradation gas phase sequencer (model HP G1005A; Hewlett-Packard, Palo Alto, Calif.).
Competition experiment.
A cytosol fraction was prepared from the mycelia of A. parasiticus NIAH-26, which had been cultured in YES medium (5% yeast extract, 20% sucrose) at 28°C for 4 days (24). VHA (0.26 mM) was incubated with porcine esterase (0.24 mg of protein ml1; Sigma) in solution A (60 mM potassium phosphate buffer, pH 7.5, containing 10% glycerol) at 30°C for 1 h, and the VHOH formed was then extracted with ethyl acetate. The ethyl acetate extract containing VHOH was transferred to a new tube and then dried by keeping the tube open to the atmosphere in the dark. This mild evaporation was needed to reduce the production of versicolorin C from VHOH by spontaneous dehydration (22). The VHOH residue was dissolved in solution A supplemented with 40 µM OAVN and incubated with the cytosol fraction of A. parasiticus NIAH-26 (final concentration, 0.18 mg of protein ml1) at 30°C for 10 min. The reaction products were extracted with chloroform, dried, dissolved in a small volume of methanol, and then analyzed with a high-performance liquid chromatography (HPLC) apparatus (model CL-6A; Shimadzu Co., Kyoto, Japan) equipped with a Cosmosil-5Ph column (0.46 by 15 cm; Nacalai Tesuque, Kyoto, Japan). Seventy percent methanol in a 1% aqueous acetic acid solution was used as the solvent at a flow rate of 0.5 ml min1. The column was kept at 30°C, and the absorbance at 290 nm was monitored. The retention times of standard samples were as follows: OAVN, 8.0 min; AVR, 19.7 min; VHOH, 6.2 min; and VB, 12.3 min.
Expression of recombinant VHOH cyclase in P. pastoris.
A Pichia expression kit (Invitrogen, Groningen, The Netherlands) was used to express VHOH cyclase. The coding region in the VHOH cyclase gene, vbs, was amplified by PCR using the cDNA of A. parasiticus NIAH-26 as a template and primers vbs-EcoRI-F (GGAATTCACCATGGGAGGAAACTGGTTCCCA) and vbs-EcoRI-R (GGAATTCTACTGCCCAGCCATCATTTCA), which had been designed based on the 5'- and 3'-terminal nucleotide sequences of the vbs gene (15). These primers each contained an additional EcoRI restriction site. The PCR product was ligated to the pHIL-D2 vector, and the resulting plasmid was transformed into the Pichia GS115 strain. Screening of the transformant, expression of the gene, and preparation of the cell extract were done according to the manufacturer's instructions accompanying the Pichia expression kit (Invitrogen). After the transformant was screened on MD medium (1.34% yeast nitrogen base with ammonium sulfate and without amino acids [YNB], 4 x 105% biotin, and 1% dextrose), the recombinant enzyme was induced by incubating the recombinant in BMMY medium (1% yeast extract, 2% peptone, 100 mM potassium phosphate [pH 6.0], 1.34% YNB, 4 x 105% biotin, 0.5% methanol) after growth in BMGY medium (1% yeast extract, 2% peptone, 100 mM potassium phosphate [pH 6.0], 1.34% YNB, 4 x 105% biotin, 1% glycerol). The intracellular fraction of the vbs recombinant was prepared by disrupting the yeast with glass beads. To confirm VHOH cyclase activity, we incubated 50 µM VHA with the cell extract (45 µg ml1) of vbs-transformed cells and 0.2 mg ml1 porcine esterase in solution A (total volume, 25 µl) at 30°C for 60 min. To check OAVN cyclase activity, we incubated 50 µM OAVN with the same cell extract. pHIL-D2 vector-transformed cell extract was used as a control. The reaction products were extracted with chloroform, and the chloroform solution was spotted onto a silica gel thin-layer chromatography (TLC) plate (Silica Gel 60; Merck, Rahway, N.J.), which was developed with benzene-ethyl acetate (1:1, vol/vol). Fluorescence of the reaction products was observed under 365-nm UV light.
Construction of the vbs disruption vector and transformation.
The replacement vector for the vbs gene was constructed by the following three-step procedure. First, the 4.3-kb fragment containing the vbs coding region and both the 5' and 3' flanking regions was amplified with vbs-HindIII-F (CCCCAAGCTTGGCGACATTTGAGCACCG) and vbs-EcoRI-R2 (GGAATTCCTCCTAGCTGGATCGGAC) as the primers and genomic DNA of strain SYS-4 (= NRRL 2999) as the template. Second, the resultant HindIII/EcoRI PCR fragment was ligated into the corresponding sites in the pUC19 vector. Third, the NheI/SmaI fragment containing the vbs gene was excised from the resultant vector and replaced with the pyrithiamine-resistant gene ptrA, which had been amplified by PCR with the KOD enzyme and primers PTRI-NheI-F (CCTAGCTAGCGGGCAATTGATTACGGGATCCCA) and PTRI-SmaI-R (TCCCCCGGGTGACGATGAGCCGCTCTTGC) from the vector pPTR I (Takara Biochem, Japan). The resultant double-crossover disruption vector, pVBS-DD1, was linealized with BglII and PstI and then transformed into A. paraciticus SYS-4 by using the method of Gomi's group (5). Conidia were collected from pyrithiamine-resistant transformants after at least 4 days of culturing and then inoculated onto GY agar (2% glucose, 0.5% yeast extract, 2% agar) to check the pigment production. The transformants accumulating yellow pigment on the GY agar plate were selected as suspected vbs disruptants. The mutants were then purified by three passages on GY medium, and the spores were stored at 80°C.
Confirmation of the gene disruptions using PCR.
The vbs gene disruption was confirmed by PCR analyses. Genomic DNA of suspected vbs disruptants and recipient strains were prepared as templates by using Nucleon PhytoPure (Amersham Life Science). The primer pairs utilized depended on the different vbs gene constructs in the chromosomes of disruptants and recipient strains. The primers used for checking the vbs double-crossover disruptants were primers P1 (vbs-5'in-F; GGCGGTGGTCCCCGTG), P2 (vbs-3'in-R; GCGACACCGGCGGAAGG), P3 (vbs-F3; CGCGCGAGGAGCTCG), P4 (vbs-R3; GCCGAGGGAGACCGG), P5 (vbsin-KpnI-F; GGGGTACCGGATGGCCTGGGCAGT), P6 (vbsin-KpnI-R; GGGGTACCGGCATCGATATCGGCG), P7 (vbspro-KpnI-F; GGGTACCTGTGTAGAAATGCTGCACAG), P8 (vbs-dis-R; GGGGAAGGGTATGCAACGC), P9 (ptrA-F1; CCACTGTGGCCGCTACC), and P10 (ptrA-R1; CACCGAAGGTAGGGCCC). The PCR conditions were (i) 94°C for 5 min, (ii) 94°C for 40 s, 56°C for 40 s, and 72°C for 3 min for 35 cycles, and (iii) 72°C for 10 min. PCR products were observed by electrophoresis on a 1% agarose gel.
Enzyme assay.
Cytosol fractions were prepared from the mycelia of the disruptants and the recipient strains, which had been cultured in YES medium at 28°C for 4 days. To remove contaminating pigments, we further purified the cytosol fraction through a Sephadex G-25 M column (PD-10; Pharmacia LKB Biotechnology, Uppsala, Sweden), which was equilibrated and then eluted with a solution containing 20 mM Tris-HCl (pH 7.5), 10% (vol/vol) glycerol, 10 mM MgCl2, 0.4 mM EDTA, and 1 mM mercaptoethanol. The cytosol fraction (0.15 mg of protein per ml) was inoculated with 6 µM VHOH or 15 µM OAVN in a reaction mixture containing 60 mM potassium phosphate buffer (pH 7.5) and 10% (vol/vol) glycerol. The total volume of the reaction mixture was 50 µl in a 0.5-ml microtube. After incubation at 30°C for 10 min or 30 min, the reaction was terminated by adding 70 µl of ethyl acetate and mixing the resulting solution with a Vortex mixer. After centrifugation, an aliquot of the ethyl acetate layer was injected into the HPLC apparatus. The O-methyltransferase II reaction catalyzing the reaction from sterigmatocystin (ST) to O-methylsterigamatocystin (OMST) was examined as the non-vbs-related enzyme reaction (26). The cytosol fraction was incubated with 60 µM ST and 0.3 mM S-adenosylmethionine in the same reaction mixture at 30°C for 10 or 30 min. After extraction with ethyl acetate, the reaction products were measured using a Shimadzu HPLC apparatus (LC-6A) equipped with an octadecyl silane column (0.46 by 15 cm; Inertsil ODS-2; GL Sciences Inc.). The column was kept at 40°C, and the flow rate was 1 ml min1. Absorption at 290 nm was monitored, and the solvent system was acetonitrile-tetrahydrofuran-water (20:20:60, vol/vol/vol). The retention times of standard metabolites were as follows: OMST, 3.8 min; ST, 7.3 min; OAVN, 7.5 min; AVR, 35.5 min; VHOH, 4.3 min; and VB, 11.7 min.
Characterization of the accumulating pigments in the mycelia.
A spore suspension (about 2 x 106 spores) of disruptant DD1-16, -23, or -27 or the recipient strain SYS-4 was inoculated into 100 ml YES liquid medium (2% yeast extract, 20% sucrose) in a bottle (10 cm by 4.5 cm; depth, 15 cm), and the bottle was laid on one side to maximize the surface area of the medium. After 3 days of stationary culturing at 28°C, wet mycelia were extracted with 30 ml acetone. The acetone extract was collected, and 2 or 3 µl of the extract was then spotted onto a silica gel TLC plate (Kieselgel 60; no. 5721; Merck & Co., Rahway, N.J.) together with various standard precursors. The TLC plate was developed with benzene-ethyl acetate (7:3, vol/vol) equilibrated with 10% acetic acid. The accumulating pigments were detected as visible yellow spots or fluorescent spots under UV light (365 nm). Fluorescence photographs of red or orange anthraquinone pigments were taken using a Contax 167 camera with Kenko SL-39 UV and SO 56.2 (YA-3) filters on Kodak Tmax 400 film. Fluorescence photographs of blue or green aflatoxins were taken with the Contax 167 camera with Shott KV 450 and BG 12 filters. For preparation of the pigments from each spot, the acetone extract was spotted onto a TLC plate in line, and after development with the same solution, the part corresponding to each spot was scraped off and pigments on the silica gel were extracted with acetone. The acetone extract was supplemented with more than 5% (vol/vol) water and then kept at 20°C until it was used. To identify the pigments in the resultant extract, we injected the extract into an HPLC apparatus (Shimadzu LC-6A HPLC system) equipped with an octadecyl silane column (0.46 by 15 cm; STR-ODS-II; Shinwa Chemical Industries, Ltd.). The flow solution was acetonitorile-tetrahydrofuran-water-acetic acid (25:25:50:1, vol/vol/vol/vol). The flow rate and column temperature were 1 ml min1 and 35°C, respectively. The retention times of metabolites were compared with those of standard samples. Typical retention times were as follows: VHOH, 3.1 min; HAVN, 4.3 min; OAVN, 4.7 min; VB, 7.1 min; AVR, 18.5 min; AVN, 21.0 min; and AVF, 23.1 min.
Tip culture
A spore suspension (5 µl) of SYS-4 or one of the mutants with vbs deleted was inoculated into 250 µl of YES medium. After 4 days of culturing, the aflatoxins excreted into the medium were measured by HPLC (20).
|
|
|---|
|
View larger version (10K): [in a new window] |
FIG. 1. Alignment of the N-terminal amino acid sequence of purified OAVN cyclase. The N-terminal sequence corresponded to part of VHOH cyclase (same as VB synthase [12, 13]) which was deduced from the vbs gene (GenBank accession no. U51328). Only the N-terminal sequence of VHOH cyclase is shown.
|
![]() View larger version (16K): [in a new window] |
FIG. 2. Competition between OAVN and VHOH for OAVN cyclase. Cytosol was incubated in reaction mixtures containing 40 µM OAVN and various concentrations of VHOH, and the amounts of AVR ( ) or VB ( ) produced were then determined by HPLC. The amount of AVR produced (143 pmol/µl) in the reaction mixture without VHOH was defined as 100%. The amount of VB produced (28.5 pmol/µl) in the reaction mixture with 200 µM VHOH was defined as 100%, which was almost same as the amount in the absence of OAVN (data not shown).
|
![]() View larger version (43K): [in a new window] |
FIG. 3. Conversion of VHOH to VB and conversion of OAVN to AVR by the recombinant VHOH cyclase expressed in P. pastoris. VHA (A) or OAVN (B) was incubated with cell extract of P. pastoris. In panel A, porcine esterase was also added in order to convert VHA to VHOH for determination of the VHOH enzyme activity. The reaction products were extracted with chloroform and analyzed by TLC. Lane 1, no cell extract; lane 2, cell extract of P. pastoris transformed with only the vector; lane 3, cell extract of P. pastoris transformed with the vector containing the vbs gene. The small amount of VHOH in panel A was due to the low extraction efficiency of the high-polarity substance VHOH with chloroform.
|
![]() View larger version (52K): [in a new window] |
FIG. 4. Disruption of the vbs gene. To disrupt the vbs gene, a double-crossover disruption vector, pVBS-DD1, was constructed (A). The vector was linearized and then transformed into A. parasiticus SYS-4 (= NRRL 2999). Double-crossover recombination led to replacement of most of the vbs gene containing the start codon with the selectable marker ptrA. The long arrows show gene directions. The short arrows indicate the positions of primers used for confirmation of gene disruption. The transformants accumulating yellow pigment on a GY agar plate were obtained as the vbs disruptants. The vbs gene disruptions were confirmed by PCR analyses (B) (lanes a, recipient train SYS-4; lanes b, c, and d, vbs disruptants VBS-DD1-16, VBS-DD1-23, and VBS-DD1-27, respectively; lane M, 1-kb molecular marker) with primer pairs P5-P6 (lanes 1), P1-P2 (lanes 2), P7-P10 (lanes 3), P8- P9 (lanes 4), P3-P10 (lanes 5), and P4-P9 (lanes 6).
|
|
View this table: [in a new window] |
TABLE 1. Enzyme activities of cytosol fractions from the recipient strain and mutants with vbs deleted
|
![]() View larger version (52K): [in a new window] |
FIG. 5. Characterization of the pigments in the vbs disruptant VBS-DD1-16. Acetone extracts of the mycelia of A. parasiticus SYS-4 (lane 4, 3 µl) and VBS-DD1-16 (lane 5, 3 µl; lane 6, 2 µl) were analyzed by TLC together with precursors (lane 1, AVR; lane 2, VB; lane 3, VA and aflatoxins B1, B2, G1, and G2; lane 7, OAVN; lane 8, VHOH; lane 9, HAVN). Two kinds of conditions for taking fluorescence photographs were used for the same TLC plate to detect red or orange fluorescence of the precursors (A) and blue or green fluorescence of aflatoxins (B). Each spot from the acetone extract of VBS-DD1-16 (A) was extracted and analyzed by HPLC. HPLC chromatograms of spots a and e are shown below the TLC plates. The first peak of the HPLC chromatogram corresponded to the solvent. The spots in panel A corresponded to the following compounds: spot a, AVR and AVF; spot b, VB; spot c, AVN; spot d, OAVN; and spot e, HAVN and VHOH. The standards in panel B were aflatoxin B1 (spot a'), aflatoxins G1 and B2 (spot b'), and aflatoxin G2 (spot c')
|
|
|
|---|
![]() View larger version (18K): [in a new window] |
FIG. 6. Involvement of the same cyclase in two independent reactions, the reaction from OAVN to AVR and the reaction from VHOH to VB.
|
In similar gene disruption experiments, disruption of a monooxygenase gene such as the ordA (28) and verB genes (7, 29) caused complete inhibition of aflatoxin production. Monooxygenase usually shows rigid specificity for its substrate. However, remaining activity after deletion of a certain gene has also been reported. Deletion of the oxidoreductase nor1 gene (17) or the esterase estA gene (4) from the gene cluster did not cause complete inhibition of aflatoxin or precursor production. Most notably, about 10% of the esterase activity involved in the reaction from VHA to VHOH was carried out by an unknown cytosol enzyme(s) (4). Generally, oxidase, reductase, and esterase are common enzymes in cells, and many enzymes in these groups are present in cells. Also, they usually show wide group specificity for many substrates. In fungal cells, they may participate to a slight degree in aflatoxin biosynthesis due to its wide group specificity. In the case of the cyclase reaction from OAVN to AVR or from VHOH to VB, another unknown enzyme(s) may also nonspecifically and partially participate in the cyclization of OAVN or VHOH.
Furthermore, another possibility is that nonenzymatic dehydration of OAVN, as well as VHOH, might occur in cells. Both OAVN and VHOH are so unstable in the hydrophobic condition that they are easily converted to AVR and VB, respectively. A relatively hydrophobic microenvironment, such as a membrane surface, might provide the appropriate conditions for spontaneous cyclization. However, it is difficult to imagine this occurring in an aqueous environment in cells.
Although the same enzyme commonly catalyzes dehydration of OAVN and VHOH, these substrates appear to be quite different in their structures. The Km values of the enzyme for OAVN and VHOH were 20 µM (13) and 2.4 µM (11), respectively. As for the mechanism of the cyclase activity from OVAN to AVR, two possible pathways can be proposed (Fig. 7). OAVN is converted to AVR after two cyclizations. Compounds A and B are the intermediate candidates. Compound A is a hemiacetal of OAVN in which C-5' is linked to C-1' through an oxygen atom to form a six-member ether ring. Compound B is a hemiacetal of OAVN in which C-5' is linked to C-3 via an oxygen atom to form an eight-member ether ring. It is likely that OAVN and compound A or OAVN and compound B are in equilibrium. It is, however, still unclear whether the OAVN cyclase works in hemiacetal formation. Considering the structural similarity to VHOH, this cyclase mainly catalyzes the step from the hemiacetal intermediate (compound A or B) to AVR. The cyclization of VHOH proceeds through the following steps. The hemiacetal OH leaves the molecule by dehydration to form a double bond between C-1' and the oxygen atom adjacent to C-1'. The oxygen of the remaining 4'-OH group attaches to C-1', and then C-4' is linked to C-1' via an oxygen atom. The involvement of two alcoholic hydroxyls in compound B in the ether ring formation is the same as that of VHOH, suggesting that compound B is a real substrate of the cyclase. VHOH cyclase shows strict stereospecificity to the (1'R,2'S) configuration of VHOH (22). Taking the stereochemistry of VB and AVR into account, 4'-OH must attach to C-1' from the
-side in VHOH. On the other hand, 1'-OH must attach to C-5' from the ß-side in compound B. If this mechanism is true, the enzyme cannot recognize this stereochemical difference. More experiments are, however, needed to clarify the details of the reaction mechanisms.
![]() View larger version (14K): [in a new window] |
FIG. 7. Proposed mechanism for the reaction from OAVN to AVR and the reaction from VHOH to VB. Compounds A and B are hemiacetal forms of OAVN. OAVN may be converted to AVR through either intermediate compound A or intermediate compound B.
|
This work was supported in part by grant-in-aid BDP-04-VI-1-2 (Bio Design Project) from the Ministry of Agriculture, Forestry and Fisheries.
E.S. and Y.W. contributed equally to this work. ![]()
Present address: Department of Microbiology, College of Biological Science, China Agricultural University, Beijing 100094, China. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»